Confronta i metodi
Esamina i metodi selezionati fianco a fianco; le righe che differiscono sono evidenziate.
| Punteggio CHA₂DS₂-VASc× | Punteggio qSOFA× | |
|---|---|---|
| Campo | Valutazione clinica | Valutazione clinica |
| Famiglia | Process / pipeline | Process / pipeline |
| Anno di origine≠ | 2010 | 2016 |
| Ideatore≠ | Gregory Y. H. Lip, Robby Nieuwlaat, et al. | Sepsis-3 Taskforce |
| Tipo≠ | Atrial fibrillation stroke risk stratification | Rapid sepsis screening |
| Fonte seminale≠ | Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272. DOI ↗ | Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810. DOI ↗ |
| Alias | CHA2DS2VASc, Atrial fibrillation stroke risk | Quick SOFA, qSOFA |
| Correlati | 3 | 3 |
| Sintesi≠ | The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions. | The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing. |
| ScholarGateInsieme di dati ↗ |
|
|